Skip to content

Supraclavicular Versus Interscalene Block for Shoulder Surgery

A Prospective Randomized Comparison of Ultrasound-guided Supraclavicular and Interscalene Block in Patients Undergoing Arthroscopic Shoulder Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02486549
Enrollment
62
Registered
2015-07-01
Start date
2015-06-30
Completion date
2017-02-28
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain, Anesthesia Recovery Period, Brachial Plexus

Brief summary

The purpose of this study is to compare the supraclavicular block to interscalene block in patients undergoing arthroscopic shoulder surgery.

Detailed description

The aim of this study is to evaluate the efficacy of the supraclavicular block in comparison with interscalene block on postoperative pain, quality of recovery and side effects in patients undergoing arthroscopic shoulder surgery under general anesthesia.

Interventions

Under ultrasound guidance an insulated needle is advanced with in- plane technique into the brachial plexus sheath and 20ml 0.25% bupivacaine will be administered

PROCEDUREInterscalene Block

Under ultrasound guidance an insulated needle will be placed through the middle scalene muscle,into the interscalene groove with in-plane technique and 20ml 0.25%bupivacaine will be administered into the brachial plexus

DRUGBupivacaine

20ml 0.25% bupivacaine will be injected for brachial plexus block

DEVICEUltrasound

The Ultrasound will be used for brachial plexus visualization

Sponsors

Tokat Gaziosmanpasa University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing shoulder surgery in American Society of Anesthesiologists physical status I-II

Exclusion criteria

* with a known allergy to study medications, * chronic opioid use, * ipsilateral upper limb neurological deficits, * severe respiratory disease, * coagulopathy

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Painup to postoperative 24 hoursThe visual analog scale will be used for assessment

Secondary

MeasureTime frameDescription
Motor blockup to postoperative 24 hoursThe muscle force will be evaluated with scale 0 to 3( 0:normal muscle force, 1: reduced muscle force, 2: impaired mobility 3: paralysis
Sensory blockup to postoperative 24 hoursThe sensorial block will be assessed by pinprick test.
Adverse eventsup to postoperative 24 hoursThe number of patients with adverse events will be recorded.
Quality of recoveryin the postoperative 24 hoursThe Quality of Recovery-40 (QR40) questionnaire will be used for assessment
Systolic Blood pressure changesat time of surgeryThe blood pressure will be measured non invasively and the systolic blood pressure lower than 90 mmHg or decrease more than 20% of baseline will be accepted as a hypotension.
Heart rate changesat time of surgeryThe heart rate will be assessed via electrocardiographic monitoring and recorded as beat/minute.
Analgesics requirement timeup to postoperative 24 hoursthe first intravenous analgesic requirement time will be recorded.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026